Rechercher un article...

Loop Diabetes 2016

Community Running Type1 Running Team
Delphine, April 23, 2016

The 2nd edition of the Diabetes Loop (2016) brought together 1,296 walkers and runners. This beautiful and festive day of sports has allowed us to pay 10 € 256 to the Search for Diabetes. The successful project is that of Estelle Grasset on "gut microbiota and autoimmunity" working within the team Rémy Burcelin, INSERM U1048 -Toulouse.


Summary on Estelle Grasset Rémy Burcelin team, INSERM U1048 -Toulouse. According to the World Health Organization, since 1980, the number of people with diabetes has increased by 4 and remains a leading cause of death worldwide. All types of diabetes is concerned. A cause "infectious" is sought. Recent years have seen appear the concept of intestinal microbiota representing all the bacteria that inhabit our intestines. It has been observed that in patients with type 1 and type 2, the composition of bacteria in the microbiota was different from that of non-diabetic subjects. In laboratory animals, the colonization of germ-free mice (bacteria-free) by diabetic mice bacteria gives the first hyperglycemia. This experience is proof of causation of the microbiota in the induction of diabetes especially type 2. In type 1 diabetes, recent studies show that the autoimmune component of the disease is under the control of bacteria gut which "educate" the immune intestinal system which affects the overall immune system. Indeed, the gut is the largest reservoir of immune cells. The composition of the intestinal microbiota is an extremely important agent in the maturation of the immune system and thus its potential role in autoimmunity. In the laboratory, we have obtained results that show that the intestinal microbiota is a regulating agent of insulin secretion. The mechanisms are not known but our preliminary work shows that the alteration of the intestinal microbiota by antibiotics, prebiotics or an unbalanced diet strongly affects the intestinal immune system. Other preliminary studies suggest that this effect affects the action of a hormone produced by the intestine in response to food and called GLP-1. This hormone sends a nutritional message to the brain. The latter transmits the information to the pancreas that secretes insulin. This hormone is therefore important for the control of blood glucose. Its secretion is stimulated by glucose that is ingested and actions are diverse and their main function is to lower blood sugar: it increases insulin secretion, it decreases glucagon secretion, it reduces the emptying of the stomach ensuring gradually arrival of ingested glucose in the blood and activates satiety. Thus, our working hypothesis is that a change of intestinal microbiota, which may happen very early in the life of the intestines, contributes to the reduction of the action of GLP-1 on the nervous axis brains and intestines pancreas. This mechanism would especially involve the intestinal immune system and ultimately control of some autoimmunity. We study the mechanisms at the interface between the microbiota and nervous tract and involving the immune system. We conduct animal studies and clinical trials is being installed for the treatment of intestinal microbiota in the context of the islet of Langerhans. Thus, we will combine the action of the microbiota on the secretion of GLP-1 secretion of insulin, the study of the role of the immune system and nervous system of the intestine in the regulatory framework of secretion insulin. To go further ... Inserm - February 2016: intestinal microbiota and health Science & Outlook - August 2015: Diabetes: the microbiota play a protective role

Comments
The WDT association

Welcome on World Diabetes Tour (WDT) website, association 1901 created in 2008 by Delphine Arduini , type 1 diabetic.

WDT is an international community of patients with type 1 diabetes. WDT's mission is to connect, inspire and motivate Type 1 diabetics to live their lives to the full while controlling their diabetes. Of each and every experience we learn. And together, we are stronger!

Discover the association
T1D Challenges

Programs T1D Challenge are organized by World Diabetes Tour with Sanofi Diabète as partner. Every year since 2013, a new sports challenge (trek of several days) brought together an international team of diabetics type 1 accompanied by an experienced medical staff.

T1D Challenge are human and sporting adventures whose mission is to inspire type 1 diabetics from all over the world.

Discover the challenges
Trips

World Diabetes Tour offers several stays each year, Adventure Team, whether sporting or not, in France or at the other end of the world.

Living together a great sporting and human adventure, while learning from each other and from each experience to better manage his diabetes.

Discover the trips
Suscribe to our newsletter

Receive by email our latests news and programs (T1D Challenge, WDT Travels...)

« True happiness does not depend on any being, any external object.
It depends only on us »

Dalaï Lama